Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual reality could make depression therapy more immersive and effective

NCT ID NCT07703397

Disease control Sponsor: KTO Karatay University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study tests a new virtual reality (VR) software that delivers behavioral activation therapy for people with depression. Behavioral activation helps people re-engage in positive activities to improve mood. Participants use hand-tracking to interact with the VR environment, completing rewarding tasks. The trial compares the VR group to a waitlist control group to see if the VR program reduces depression symptoms and increases engagement.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a virtual reality software program that delivers behavioral activation therapy using hand-tracking technology
What this could lead to
If effective, this VR approach could offer a new, engaging way to deliver behavioral activation therapy for depression, potentially making treatment more accessible and appealing.
What could go wrong
This is an early-stage study with only 50 participants, so results may not apply broadly. The VR software is new and may not outperform standard therapy or may cause side effects like motion sickness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Dec 2024

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Being 18 years of age or older. * Being literate (ability to read and write). * Providing written informed consent by reading and signing the informed consent form. * Having a score of 17 or above on the Beck Depression Inventory (BDI). * Having a score of 41 or below on the Behavioral Activation subscale of the Behavioral Inhibition System and Behavioral Activation System (BIS/BAS) Scale. * Having a score of 21 or above on the Behavioral Inhibition subscale of the Behavioral Inhibition System and Behavioral Activation System (BIS/BAS) Scale. Exclusion Criteria: * Having advanced vision problems that impair visual function, such as cataracts. * Having uncorrected visual impairments, such as color blindness. * Having any psychiatric or neurological disorder characterized by impaired reality testing. * Being under 18 years of age.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Behavioral activation are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression major depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Behavioral activation Behavioral inhibition Depression - major depressive disorder Virtual reality therapy

Contacts and locations

Locations

  • Aydin Adnan Menderes University, Department of Psychology

    Aydin, 09010, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.